Please login to the form below

Not currently logged in
Email:
Password:

Astellas strengthens US and Canadian leadership team

Steve Sabus, Lynn Gerber and Kevin O’Keefe are promoted to new roles

Steve SabusAstellas has promoted Steve Sabus (pictured right) to general manager of Astellas Pharma Canada, effective from 1 April this year.

His new role will see him lead business operations in the country and he will report to Percival Barretto-Ko, Astellas’ senior vice president of international operations.

Barretto-Ko, said: “I have great confidence in Steve’s ability to continue the growth Astellas Canada, an important market in the Americas.

“His continued leadership and extensive experience in sales and marketing will help ensure that our ongoing commitment to therapies in oncology, urology, immunology and other areas will focus on Canadian patients’ needs.”

Sabus joined Astellas in 2007 and has over 25 years’ experience in the pharmaceutical industry.

He most recently served as vice president, primary care at Astellas US and prior to this, he served in various capacities for Johnson & Johnson.

Lynn GerberAs Sabus leaves from the US, Astellas has promoted Lynn Fenicchia Gerber (pictured left) to US vice president, primary care, where she will lead sales efforts for the OAB, anti-fungal, cardiovascular and transplant franchises.

Gerber joined Astellas from GSK and she has more than 25 years’ experience in the pharmaceutical industry.

Kevin O’Keefe (pictured below) has also been promoted to US area vice president, sales, primary care and speciality for the West, where he will be responsible for overseeing sales efforts and developing talent within the sales force.

Kevin O'KeefeO’Keefe has 27 years’ experience in the pharmaceutical industry, with 20 years in sales leadership.

Prior to joining Astellas, O’Keefe worked with Bayer and Oscient in roles of increasing responsibility.

6th February 2018

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Biosimilars and beyond: innovating for improved patient outcomes
How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...